1.
Cost-effectiveness of sacubitril/valsartan in chronic heart-failure patients with reduced ejection fraction. Swiss Med Wkly [Internet]. 2017 Nov. 15 [cited 2025 Nov. 10];147(4546):w14533. Available from: https://www.smw.ch/index.php/smw/article/view/2401